Telesis Bio’s stock skyrocketed in pre-market trading after announcing a partnership with Beckman Coulter Life Sciences. Other notable pre-market movers include Kintara Therapeutics, Fangdd Network Group, and NuCana, while Micron Technology and Gaotu Techedu saw gains. On the downside, VS MEDIA Holdings, MDxHealth, and Pagaya Technologies saw significant drops.
Telesis Bio’s stock surged in after-hours trading on Wednesday after announcing a partnership with Beckman Coulter Life Sciences to create efficient and scalable biofoundries for DNA synthesis. The partnership combines Telesis Bio’s cutting-edge Gibson SOLA technology with Beckman Coulter’s automation expertise, promising to transform the landscape of synthetic biology.
